May 19, 2015 7:28am

BLUE pursues conditional and accelerated registration strategies in E.U. and U.S., Respectively

Plans to pursue conditional approval in E.U. based on data from ongoing Northstar and HGB-205 studies through Adaptive Pathways Pilot Program

NIH RAC will review HGB-208 Pediatric Study Protocol on 6/9/15

 


Members only. Please login.